SCHEMBL29831609

SCHEMBL29831609

CCOC(=O)c1sc(Nc2nc(NCc3cccc(OC)c3)cc(N3CCNCC3)n2)nc1C

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 7/20 0.81
▸ ALDH1A1 P00352 4/20 0.49
▸ MAPT P10636 4/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ LMNA P02545 2/20 0.47
▸ PDE2A O00408 1/20 0.46
▸ PDE3B Q13370 1/20 0.46
▸ PDE3A Q14432 1/20 0.46
▸ CRHBP P24387 1/20 0.46
▸ CRHR2 Q13324 1/20 0.46
▸ KIFC1 Q9BW19 1/20 0.45
▸ GALR2 O43603 1/20 0.44
▸ DHODH Q02127 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290969 1.00 PDE5A (0.81) PDE5AALDH1A1MAPTKDM4ELMNA
SCHEMBL2680247 0.92 PDE5A (0.81) PDE5AALDH1A1MAPTKDM4ELMNA
SCHEMBL291090 0.92 PDE5A (0.84) PDE5AALDH1A1MAPTKDM4ELMNA
SCHEMBL290392 0.92 PDE5A (0.81) PDE5AALDH1A1MAPTKDM4ELMNA
SCHEMBL29408496 0.91 PDE5A (0.76) PDE5AALDH1A1MAPTKDM4ELMNA
SCHEMBL290209 0.91 PDE5A (0.76) PDE5AALDH1A1MAPTKDM4ELMNA
SCHEMBL29408497 0.90 PDE5A (0.75) PDE5AALDH1A1MAPTKDM4ELMNA
SCHEMBL29408509 0.90 PDE5A (1.00) PDE5AALDH1A1MAPTKDM4ELMNA
SCHEMBL28564661 0.90 PDE5A (1.00) PDE5AALDH1A1MAPTKDM4ELMNA
SCHEMBL2680202 0.88 PDE5A (0.81) PDE5AALDH1A1MAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 — — EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 — — WO disclosed
CN-115192711-A Use of PDE7 inhibitors for the treatment of movement disorders 奥默罗斯公司 2022-10-18 — — CN disclosed
CN-114984229-A Treatment of addiction and impulse control disorders using PDE7 inhibitors 奥默罗斯公司 2022-09-02 — — CN disclosed
Send feedback